Navigation Links
Advanced Assay Technologies and Development Methods
Date:1/13/2011

LOS ANGELES, Jan. 13, 2011 /PRNewswire/ -- UBM Canon and IVD Technology are proud to add a new webinar to its webcast series on The Fundamentals of In Vitro Diagnostics.  This one-hour event will focus specifically on Advanced Assay Technologies and Development Methods and will offer an in-depth analysis and discussion from experts in the industry.  

(Logo:  http://photos.prnewswire.com/prnh/20101214/LA16070LOGO)

Various market reports and studies have concluded that the future for immunoassays is a mixed bag. In the clinical laboratory, mature assays will show moderate growth while emerging assays will fuel most of the growth in this IVD segment. However, all immunoassays will have to pass the test of medical research to demonstrate their contributions to improving patient outcomes. In this webinar event, attendees will learn more about how immunoassays, combined with DNA probe studies, will have an important place in post-genomic medicine.

This Webcast will feature presentations by Neal Siegel, PhD, Chief Scientific Officer, Sword Diagnostics; Scott Dylewski, PhD, Senior Scientist, Alverix Inc.; and Nick Gee, PhD, CEO/CSO, Innova Biosciences Ltd. The Webcast concludes with a live Q&A session moderated by Richard Park, Editor-in-Chief of IVD Technology magazine.  For more information on our speakers, click here.  

Rich Nass, Content Director for the Medical Device Media Group, stated, "All attendees will receive a copy of our special DX Directions report on Advanced Assay Technologies, giving this event a real value-added feature." This Webcast will take place on Wednesday, January 26 at 2:00 p.m. ET (1:00 p.m. CT, 11:00 a.m. PT).  There is a small registration fee to attend.  The event will be archived for six months on the IVD Technology website and UBM Canon Medical Device Media Group's webcast archive.  For more information or to register for the event, please click here.  

About UBM Canon

UBM Canon, the leading B-to-B media company dedicated exclusively to the global $3.0 trillion advanced manufacturing sector, helps support the flow of information, commerce and innovation in such sophisticated segments as medical devices and pharmaceutical development. UBM Canon also addresses cutting-edge developments in broader areas of advanced engineering design and manufacturing, and manufacturing processes and packaging. UBM Canon is part of UBM (UBM.L) a global provider of media and information services for professional B2B communities and markets.


'/>"/>
SOURCE UBM Canon
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)
2. CoreLab Partners Launches Advanced Imaging Application
3. Advanced Life Sciences to Explore Strategic Alternatives to Maximize Shareholder Value
4. Advanced Laser Therapy Solutions for Womens Hair Loss
5. Centocor Ortho Biotech Inc. Announces NDA Submission for Abiraterone Acetate for the Treatment of Metastatic Advanced Prostate Cancer
6. Improvements in Recurrence-Free Survival in Early Stages of Colorectal Cancer Will Limit Growth of Drug Treatment Opportunities for Advanced Disease
7. Advanced Radiology Introduces Baltimores First 1.2T High Field Open MRI
8. EGEN, Inc. Announces that Phase II Clinical Trial for Advanced Ovarian Cancer is Open for Enrollment
9. Advanced BioHealing Appoints Kevin C. OBoyle as Chief Financial Officer
10. Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients
11. New Subgroup Analysis of LUX-Lung 1 Trial Suggests Afatinib Increases Progression-Free Survival in Advanced Lung Cancer Patients More Likely to Have EGFR Mutations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... , Dec. 7, 2016  The Corporate ... healthcare manager to call them anytime at 866-714-6466 if ... managers to sell more drugs. Aside from the innocent ... taxpayers as well, because often-times these practices target Medicare recipients ... http://photos.prnewswire.com/prnh/20161206/446240 ...
(Date:12/7/2016)... READING, Mass. , Dec. 7, 2016 /PRNewswire/ ... and Trace Network for connecting the Life Sciences ... the global marketplace, today announced that Tjoapack has ... European pharmaceutical manufacturing customers comply with the rapidly ... Chain Security Act (DSCSA) in 2017 and the ...
(Date:12/7/2016)... 2016 According to responses from U.S. oncologists that ... of patients with non-small cell lung cancer (NSCLC), treatment decisions ... genetic mutation status. The findings of the survey were presented ... #P3.02b ) at the 2016 World Conference on Lung ... The survey results revealed an overall high rate of ...
Breaking Medicine Technology:
(Date:12/7/2016)... TX (PRWEB) , ... OCTOBER XX, 2016 (PRWEB) ... ... help solve another mystery. A new study entitled “Canine Filamentous Dermatitis Associated ... disease can occur in dogs. The study was published in the prestigious Journal ...
(Date:12/7/2016)... ... 07, 2016 , ... Texas Premier Locksmith , a ... by unethical locksmith companies and is urging Search Engines to improve verification methods ... Premier Locksmith, these fraudulent locksmith services take advantage of consumers locked out of ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... newest portable bioelectronic medicine device WellnessPro Plus for consumers and healthcare professionals ... the WellnessPro platform by expanding the treatment modalities available in a single ...
(Date:12/7/2016)... ... , ... “Fred Rides a Train” allows readers to tag along on a ... a Train” is the creation of published author, Janet Morrison, who has been writing ... The "Fred, the Dog" series is her first attempt at writing for children. Janet, ...
(Date:12/7/2016)... , ... December 07, 2016 , ... "Hacking into my ... had described him as 'a genius.'" Thus begins "Margaret in Berlin," Book Twelve in ... published by Wyston Books, Inc. These novels narrate the lives of a ...
Breaking Medicine News(10 mins):